Masimo Corporation is a global medical technology company that develops and produces a wide range of monitoring technologies, including measurements, sensors, patient monitors, automation and connectivity solutions. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. It primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
企業コードMASI
会社名Masimo Corp
上場日Aug 08, 2007
最高経営責任者「CEO」Szyman (Catherine M)
従業員数3600
証券種類Ordinary Share
決算期末Aug 08
本社所在地52 Discovery
都市IRVINE
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号92618
電話番号19492977000
ウェブサイトhttps://www.masimo.com/
企業コードMASI
上場日Aug 08, 2007
最高経営責任者「CEO」Szyman (Catherine M)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし